1
|
Muigg F, Zelger P, Rossi S, Kühn H, Schmutzhard J, Graf S, Weichbold V. Health-related quality of life in vibrant soundbridge patients: generic and specific measures, short-term and long-term outcomes. Eur Arch Otorhinolaryngol 2024:10.1007/s00405-024-08889-2. [PMID: 39179912 DOI: 10.1007/s00405-024-08889-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2024] [Accepted: 07/31/2024] [Indexed: 08/26/2024]
Abstract
OBJECTIVE The goal of the study was to determine the short- and long-term outcome of health-related quality of life (HRQoL) in adults implanted with a Vibrant Soundbridge (VSB). METHODS Twenty-one adults (8 females, 13 males; mean age at implantation: 57 ±10 years) who received a unilateral VSB for combined or conductive hearing loss, were administered two questionnaires: the Nijmegen Cochlear Implant Questionnaire (NCIQ) as a measure of hearing-specific HRQoL, and the Health Utility Index 3 (HUI 3) as a measure of generic HRQoL. The questionnaires were administered before implantation and three, six, 12 and 24 months after processor activation. RESULTS The NCIQ total score raised significantly from 62 points before implantation to 76 points at three months after processor activation (p < 0.005). Thereafter, no significant increases occurred anymore. The HUI 3 multi-attribute score (MAUS) increased from 0.59 before implantation to 0.70 at three months and at six months after processor activation and then declined slightly to 0.68 at 24 months after processor activation. Similar values were observed with the HUI 3 single-attribute score (SAUS) of Hearing. The increases of the HUI 3 scores were not statistically significant, but all pre-post-implantation differences were clinically relevant. DISCUSSION VSB recipients experienced a quick improvement of their HRQoL. After just three months of device use, a significant improvement of hearing-specific HRQoL and a clinically relevant improvement of generic HRQoL were seen. After three months, no essential changes of HRQoL occurred in our sample, suggesting that the achieved level of HRQoL may remain stable in the long term.
Collapse
Affiliation(s)
- Franz Muigg
- Speech & Voice Disorders, University Hospital for Hearing, Medical University of Innsbruck, Innsbruck, Austria
| | - Philipp Zelger
- Speech & Voice Disorders, University Hospital for Hearing, Medical University of Innsbruck, Innsbruck, Austria.
- ICONE - Innsbruck Cognitive Neuroscience, Medical University of Innsbruck, Innsbruck, Austria.
| | - Sonja Rossi
- Speech & Voice Disorders, University Hospital for Hearing, Medical University of Innsbruck, Innsbruck, Austria
- ICONE - Innsbruck Cognitive Neuroscience, Medical University of Innsbruck, Innsbruck, Austria
| | - Heike Kühn
- Comprehensive Hearing Center Würzburg, University-ENT-Hospital, Würzburg, Germany
| | - Joachim Schmutzhard
- Department of Otorhinolaryngology-Head and Neck Surgery, Medical University of Innsbruck, Innsbruck, 6020, Austria
| | - Simone Graf
- Speech & Voice Disorders, University Hospital for Hearing, Medical University of Innsbruck, Innsbruck, Austria
| | - Viktor Weichbold
- Speech & Voice Disorders, University Hospital for Hearing, Medical University of Innsbruck, Innsbruck, Austria
| |
Collapse
|
2
|
Alasmi A, Saleh S, Anderson I, Abdelsamad Y, Hagr A. Validation of the Arabic language version of the Audio Processor Satisfaction Questionnaire (APSQ) for hearing implant users. PLoS One 2024; 19:e0303301. [PMID: 38857266 PMCID: PMC11164331 DOI: 10.1371/journal.pone.0303301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2023] [Accepted: 04/23/2024] [Indexed: 06/12/2024] Open
Abstract
OBJECTIVE Audio processors (AP) are the external components of hearing implants. User satisfaction with the performance and comfort of their AP is a critical factor in ensuring daily use, which leads to improved hearing outcomes. The aim of this study was to construct and validate an Arabic language translation of the APSQ for use among Arabic-speaking clinicians and patients. DESIGN The original APSQ was translated into the Arabic language using cross-cultural adaptation measures. The final questionnaire was administered to CI users in electronic form. STUDY SAMPLE 117 CI users (64 female) participated. A total of 179 ears were assessed. RESULTS High levels of satisfaction with audio processors were observed among CI users. Item and scale analyses indicate that this version of the APSQ measure a homogeneous and valid construct. CONCLUSION The Arabic version of the APSQ captures user satisfaction with hearing implant audio processors.
Collapse
Affiliation(s)
- Abdulaziz Alasmi
- King Abdullah Ear Specialist Center (KAESC), King Abdulaziz University Hospital, King Saud University Medical City, Riyadh, Saudi Arabia
| | - Shaza Saleh
- King Abdullah Ear Specialist Center (KAESC), King Abdulaziz University Hospital, King Saud University Medical City, Riyadh, Saudi Arabia
| | - Ilona Anderson
- Clinical Research Department, MED-EL GmbH, Innsbruck, Austria
| | | | - Abdulrahman Hagr
- King Abdullah Ear Specialist Center (KAESC), King Abdulaziz University Hospital, King Saud University Medical City, Riyadh, Saudi Arabia
| |
Collapse
|
3
|
Lassaletta L, Calvino M, Sanchez-Cuadrado I, Skarzynski PH, Cywka KB, Czajka N, Kutyba J, Tavora-Vieira D, Van de Heyning P, Mertens G, Staecker H, Humphrey B, Zernotti M, Zernotti M, Magele A, Ploder M, Zabeu JS. QoL, CIs, QALYs, and Individualized Rehabilitation: The Clinical and Practical Benefits of Regularly Assessing the Quality of Life of Adult Cochlear Implant Recipients. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:6906. [PMID: 37887644 PMCID: PMC10605987 DOI: 10.3390/ijerph20206906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Revised: 08/24/2023] [Accepted: 10/01/2023] [Indexed: 10/28/2023]
Abstract
This study aimed to report quality of life (QoL) scores in unilateral cochlear implant (CI) users and to generate guidance for clinicians on using QoL measures to individualize CI counselling and rehabilitation and to increase access to CIs as a mode of rehabilitation. Participants (n = 101) were unilateral CI users with single-sided deafness (SSD; n = 17), asymmetrical hearing loss (AHL; n = 26), or bilateral hearing loss (Uni; n = 58). Generic QoL was assessed via the Health Utilities Index (HUI-3), and disease-specific QoL was assessed via the Speech, Spatial, and Qualities of Hearing scale (SSQ12) and Nijmegen CI Questionnaire (NCIQ) at preimplantation and at 6 and 12 months of CI use. All groups had significantly increased HUI-3 scores at both intervals. The SSD group showed significant benefit on the SSQ12 at visit 3, the AHL group showed significant benefit on the SSQ12 and most NCIQ subdomains at both intervals, and the Uni group showed significant benefit with both tests at both intervals. Unilateral CI recipients demonstrate improved QoL within the first 12 months of device use. Regular assessment with generic and disease-specific questionnaires has the potential to play an important role in personalizing treatment and possibly in increasing access to CI provision.
Collapse
Affiliation(s)
- Luis Lassaletta
- Department of Otorhinolaryngology, Hospital La Paz. IdiPAZ Research Institute, 28046 Madrid, Spain; (M.C.); (I.S.-C.)
- Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, (CIBERER-U761), 28029 Madrid, Spain
| | - Miryam Calvino
- Department of Otorhinolaryngology, Hospital La Paz. IdiPAZ Research Institute, 28046 Madrid, Spain; (M.C.); (I.S.-C.)
- Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, (CIBERER-U761), 28029 Madrid, Spain
| | - Isabel Sanchez-Cuadrado
- Department of Otorhinolaryngology, Hospital La Paz. IdiPAZ Research Institute, 28046 Madrid, Spain; (M.C.); (I.S.-C.)
| | - Piotr Henryk Skarzynski
- Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland; (P.H.S.); (K.B.C.); (N.C.); (J.K.)
| | - Katarzyna B. Cywka
- Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland; (P.H.S.); (K.B.C.); (N.C.); (J.K.)
| | - Natalia Czajka
- Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland; (P.H.S.); (K.B.C.); (N.C.); (J.K.)
| | - Justyna Kutyba
- Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland; (P.H.S.); (K.B.C.); (N.C.); (J.K.)
| | | | - Paul Van de Heyning
- Department of Otorhinolaryngology, Antwerp University Hospital, 2650 Antwerp, Belgium; (P.V.d.H.); (G.M.)
| | - Griet Mertens
- Department of Otorhinolaryngology, Antwerp University Hospital, 2650 Antwerp, Belgium; (P.V.d.H.); (G.M.)
| | - Hinrich Staecker
- ENT Department, University of Kansas Medical Centre, Kansas City, KS 66160, USA; (H.S.); (B.H.)
| | - Bryan Humphrey
- ENT Department, University of Kansas Medical Centre, Kansas City, KS 66160, USA; (H.S.); (B.H.)
| | - Mario Zernotti
- Department of Otorhinolaryngology, Sanatorio Allende de Córdoba, Córdoba 5000, Argentina; (M.Z.); (M.Z.)
| | - Maximo Zernotti
- Department of Otorhinolaryngology, Sanatorio Allende de Córdoba, Córdoba 5000, Argentina; (M.Z.); (M.Z.)
| | - Astrid Magele
- ENT Department, Universitätsklinikum St. Pölten, 3100 St. Pölten, Austria; (A.M.)
| | - Marlene Ploder
- ENT Department, Universitätsklinikum St. Pölten, 3100 St. Pölten, Austria; (A.M.)
| | - Julia Speranza Zabeu
- Hospital de Reabilitacão de Anomalias Craniofaciais da Universidade de Sao Paulo, Campus Bauru, Bauru 17012-230, Brazil;
| |
Collapse
|
4
|
Calvino M, Sánchez-Cuadrado I, Gavilán J, Lassaletta L. Long-Term Non-Users of Transcutaneous Auditory Implants: Thirty Years of Experience at a Single Institution. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:6201. [PMID: 37444049 PMCID: PMC10341118 DOI: 10.3390/ijerph20136201] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 06/14/2023] [Accepted: 06/20/2023] [Indexed: 07/15/2023]
Abstract
Background: Although it is a recognized phenomenon, there is little published in the literature on the discontinuation of auditory implant use. Aim: To evaluate the incidence of device non-use of transcutaneous auditory implants. Patients and Methods: This is a retrospective study of all living individuals (children and adults) implanted at the La Paz Hospital (Madrid, Spain) between 1992-2015, with a follow-up examination endpoint of December 2022. 356 device recipients were included: 316 with cochlear implants (CI), 22 with middle-ear implants (Vibrant Soundbridge, VSB), and 18 with bone conduction implants (Bonebridge, BB). Results: Nine CI recipients (2.8%) were identified as non-users (mean follow-up 15.1 ± 5.4 years). The reasons for non-use were implant failure and reimplantation rejection, lack of benefit, non-attendance of rehabilitation sessions, loss of the audio processor, and cognitive and linguistic difficulties. None of them experienced any surgical complications. Six VSB recipients (27.3%) were device non-users (mean follow-up 11.4 ± 2.1 years). All of them experienced device failure or surgical complications. To date, none of the BB recipients is a non-user (mean follow-up 8.6 ± 1.1 years). Conclusion: The rates of non-use of transcutaneous auditory implants vary widely between different types of implants. Given the small proportion of non-users, information on what are the predictive factors could not be determined. The reasons for non-use should be carefully documented and used to guide careful patient selection to reduce the risk of non-use in future candidates.
Collapse
Affiliation(s)
- Miryam Calvino
- Department of Otolaryngology, Hospital Universitario La Paz, IdiPAZ Research Institute, 28046 Madrid, Spain
- Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, CIBERER-U761, 28029 Madrid, Spain
| | - Isabel Sánchez-Cuadrado
- Department of Otolaryngology, Hospital Universitario La Paz, IdiPAZ Research Institute, 28046 Madrid, Spain
| | - Javier Gavilán
- Department of Otolaryngology, Hospital Universitario La Paz, IdiPAZ Research Institute, 28046 Madrid, Spain
| | - Luis Lassaletta
- Department of Otolaryngology, Hospital Universitario La Paz, IdiPAZ Research Institute, 28046 Madrid, Spain
- Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, CIBERER-U761, 28029 Madrid, Spain
| |
Collapse
|
5
|
Ratuszniak A, Lorens A, Obrycka A, Witkowska J, Skarzynski H, Skarzynski PH. New technology can benefit established middle ear implant users: Samba 2 vs previous models of audio processors for Vibrant Soundbridge. Eur Arch Otorhinolaryngol 2022; 280:2387-2396. [PMID: 36441245 PMCID: PMC10066116 DOI: 10.1007/s00405-022-07741-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Accepted: 11/02/2022] [Indexed: 11/29/2022]
Abstract
Abstract
Introduction
The Vibrant Soundbridge (VSB) is a semi-implantable hearing aid for patients with various types of hearing loss and has been available for over 25 years. Recently, new audio processors with advanced signal processing, noise reduction, and multi-microphone technology have appeared. The aim of this study is to compare the benefits of using the newest Samba 2 processor to the previous generation processors in a group of experienced VSB users.
Methods
There were 22 experienced VSB users (mean time of using VSB was 9 years, SD = 2) who had their processor (D404 or Amadé) upgraded to the newest model (Samba 2). The mean age of the subjects was 56 years (SD = 20). Assessments were made by free-field audiometry, speech reception in quiet and noise, and Patient-Reported Outcome Measures (PROMs).
Results
Hearing tests in free field showed statistically significant improvements in hearing sensitivity and speech discrimination in quiet and noise with the Samba 2 audio processor compared to the earlier technology. PROMs confirmed the benefits of using the newest audio processor and there was more satisfaction in terms of usability.
Conclusions
Access to modern technology for VSB patients provides measurable benefits.
Collapse
Affiliation(s)
- Anna Ratuszniak
- Otorhinolaryngosurgery Clinic, World Hearing Center, Institute of Physiology and Pathology of Hearing, Mochnackiego 10 Str., 02-042, Warsaw, Poland.
| | - Artur Lorens
- Implant and Auditory Perception Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, Mochnackiego 10 Str., 02-042, Warsaw, Poland
| | - Anita Obrycka
- Implant and Auditory Perception Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, Mochnackiego 10 Str., 02-042, Warsaw, Poland
| | - Justyna Witkowska
- Implant and Auditory Perception Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, Mochnackiego 10 Str., 02-042, Warsaw, Poland
| | - Henryk Skarzynski
- Otorhinolaryngosurgery Clinic, World Hearing Center, Institute of Physiology and Pathology of Hearing, Mochnackiego 10 Str., 02-042, Warsaw, Poland
| | - Piotr Henryk Skarzynski
- Department of Teleaudiology and Hearing Screening, World Hearing Center, Institute of Physiology and Pathology of Hearing, Mochnackiego 10 Str., 02-042, Warsaw, Poland
- Heart Failure and Cardiac Rehabilitation Department, Medical University of Warsaw, 8 Kondratowicza Str., 03-242, Warsaw, Poland
- Institute of Sensory Organs, Mokra 1 Str., 05-830, Kajetany, Poland
| |
Collapse
|
6
|
Illg A, Lukaschyk J, Kludt E, Lesinski-Schiedat A, Billinger-Finke M. Do Not Go Gentle into That Deaf Night: A Holistic Perspective on Cochlear Implant Use as Part of Healthy Aging. J Pers Med 2022; 12:1658. [PMID: 36294797 PMCID: PMC9605441 DOI: 10.3390/jpm12101658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2022] [Revised: 09/26/2022] [Accepted: 09/28/2022] [Indexed: 11/06/2022] Open
Abstract
Research suggests that cochlear implant (CI) use in elderly people improves speech perception and health-related quality of life (HRQOL). CI provision could also prevent dementia and other comorbidities and support healthy aging. The aim of this study was (1) to prospectively investigate potential changes in HRQOL and speech perception and (2) to identify clinical action points to improve CI treatment. Participants (n = 45) were CI recipients aged 60-90 with postlingual deafness. They were divided into groups, according to age: Group 1 (n = 20) received a CI between the age of 60-70 years; group 2 (n = 25) between the age of 71-90 years. HRQOL and speech perception were assessed preoperatively, and three and twelve months postoperatively. HRQOL and speech perception increased significantly within one year postoperatively in both groups. No difference between groups was found. We conclude that CI treatment improves speech perception and HRQOL in elderly users. Improvement of the referral process for CI treatment and a holistic approach when discussing CI treatment in the elderly population could prevent auditory deprivation and the deterioration of cognitive abilities.
Collapse
Affiliation(s)
- Angelika Illg
- German Hearing Center, Department of Otorhinolaryngology, Medical University Hannover, Karl-Wiechert-Allee 3, 30625 Hannover, Germany
| | - Julia Lukaschyk
- German Hearing Center, Department of Otorhinolaryngology, Medical University Hannover, Karl-Wiechert-Allee 3, 30625 Hannover, Germany
| | - Eugen Kludt
- German Hearing Center, Department of Otorhinolaryngology, Medical University Hannover, Karl-Wiechert-Allee 3, 30625 Hannover, Germany
| | - Anke Lesinski-Schiedat
- German Hearing Center, Department of Otorhinolaryngology, Medical University Hannover, Karl-Wiechert-Allee 3, 30625 Hannover, Germany
| | - Mareike Billinger-Finke
- German Hearing Center, Department of Otorhinolaryngology, Medical University Hannover, Karl-Wiechert-Allee 3, 30625 Hannover, Germany
- MED-EL GmbH, 6020 Innsbruck, Austria
| |
Collapse
|